Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Equity: 2011-2025

Historic Return on Equity for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Sep 2025 value amounting to -0.46%.

  • Ironwood Pharmaceuticals' Return on Equity fell 118.00% to -0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.46%, marking a year-over-year decrease of 118.00%. This contributed to the annual value of -0.32% for FY2024, which is 790.00% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Return on Equity stood at -0.46% for Q3 2025, which was down 55.69% from -0.29% recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Equity peaked at 3.87% during Q1 2024, and registered a low of -5.25% during Q2 2023.
  • Its 3-year average for Return on Equity is 0.51%, with a median of 0.27% in 2023.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Return on Equity soared by 813bps in 2021 and then plummeted by 558bps in 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Equity (Quarterly) stood at 0.89% in 2021, then crashed by 61bps to 0.28% in 2022, then surged by 346bps to 3.74% in 2023, then plummeted by 408bps to -0.34% in 2024, then slumped by 118bps to -0.46% in 2025.
  • Its Return on Equity stands at -0.46% for Q3 2025, versus -0.29% for Q2 2025 and -0.22% for Q1 2025.